Larvol Delta - 23andMe-Therapeutics-Announces-Positive-In-Vivo-Results-for-23ME01473-a-DualMechanism-ULBP6Targeting-Antibody-Currently-in-a-Phase-1-Trial

23ME-01473 - 23andMe

https://www.globenewswire.com/news-release/2024/09/15/2946280/0/en/23andMe-Therapeutics-Announces-Positive-In-Vivo-Results-for-23ME-01473-a-Dual-Mechanism-ULBP6-Targeting-Antibody-Currently-in-a-Phase-1-Trial.html

Sep 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next